

What is Estradiol/Norethindrone/Relugolix (Myfembree)? Learn about its uses for fibroids and endometriosis, dosage, cost, and what you need to know in 2026.
Estradiol/Norethindrone/Relugolix is a once-daily oral combination medication used to treat heavy menstrual bleeding from uterine fibroids and moderate to severe pain from endometriosis in premenopausal women.
Sold under the brand name Myfembree, this medication combines three active ingredients into a single tablet: Relugolix (a GnRH receptor antagonist that suppresses hormone production), Estradiol (a form of estrogen), and Norethindrone Acetate (a progestin). The Estradiol and Norethindrone components serve as "add-back therapy" — they replace just enough hormone to prevent the worst menopause-like side effects and protect your bones while the Relugolix does its job.
Myfembree is manufactured by Myovant Sciences, a Sumitovant Biopharma company (subsidiary of Sumitomo Pharma).
Myfembree is FDA-approved for two conditions:
Uterine fibroids are noncancerous growths in the uterus that affect up to 80% of women by age 50. When fibroids cause heavy periods — the kind that soak through a pad or tampon every hour, cause large clots, or last more than 7 days — Estradiol/Norethindrone/Relugolix can significantly reduce that bleeding. In clinical trials, the majority of women experienced a meaningful reduction in menstrual blood loss.
Endometriosis occurs when tissue similar to the uterine lining grows outside the uterus, causing chronic pain, painful periods, and pain during intercourse. Myfembree was approved in August 2023 for managing moderate to severe pain associated with endometriosis in premenopausal women.
Some providers may prescribe Estradiol/Norethindrone/Relugolix off-label for adenomyosis symptom management or as a preoperative treatment to reduce fibroid size before surgery (myomectomy or hysterectomy).
Myfembree is taken as one tablet by mouth, once daily, at approximately the same time each day. Here are the details:
For information on how this medication works in your body, see our article on how Estradiol/Norethindrone/Relugolix works.
Myfembree is not appropriate for everyone. It is contraindicated (should not be used) in the following situations:
Myfembree also carries a boxed warning about thromboembolic disorders and vascular events. Learn more about what to watch for in our side effects guide.
Cost is a significant factor for this medication:
For a complete breakdown of savings options, see our guide on how to save money on Estradiol/Norethindrone/Relugolix.
Estradiol/Norethindrone/Relugolix (Myfembree) represents a meaningful advance in treating uterine fibroids and endometriosis. It's the first once-daily oral combination that includes both a GnRH antagonist and hormonal add-back therapy in a single tablet, making it more convenient than older treatments that required multiple pills or injections.
If you think Myfembree might be right for you, talk to your OB/GYN or find a prescriber using our guide on how to find a doctor who prescribes Estradiol/Norethindrone/Relugolix. And when you're ready to fill your prescription, Medfinder can help you find a pharmacy with it in stock.
Find Estradiol/Norethindrone/Relugolix in stock near you with Medfinder →
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.